OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of DMPK science in improving pharmaceutical research and development efficiency
Kit‐Kay Mak, Ola Epemolu, Mallikarjuna Rao Pichika
Drug Discovery Today (2021) Vol. 27, Iss. 3, pp. 705-729
Closed Access | Times Cited: 14

Showing 14 citing articles:

Emerging trends in organ-on-a-chip systems for drug screening
Yanping Wang, Yanfeng Gao, Yongchun Pan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2483-2509
Open Access | Times Cited: 50

Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction
Yoochan Myung, Alex G. C. de Sá, David B. Ascher
Nucleic Acids Research (2024) Vol. 52, Iss. W1, pp. W469-W475
Open Access | Times Cited: 39

Artificial Intelligence in Drug Discovery and Development
Kit‐Kay Mak, Yi-Hang Wong, Mallikarjuna Rao Pichika
Springer eBooks (2023), pp. 1-38
Closed Access | Times Cited: 30

Artificial Intelligence in Drug Discovery and Development
Kit‐Kay Mak, Yi-Hang Wong, Mallikarjuna Rao Pichika
Springer eBooks (2024), pp. 1461-1498
Closed Access | Times Cited: 8

Spirocyclic compounds as innovative tools in drug discovery for medicinal chemists
Marina T. Varela, Gleiston G. Dias, Luiz Fernando N. de Oliveira, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117368-117368
Closed Access | Times Cited: 1

The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery
Glory P. Adebayo, Opeyemi I. Ayanda, Matthias Rottmann, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 424-424
Open Access

Current and emerging approaches to noncompetitive AR inhibition
Christopher M. Riley, J Mark Elwood, Martyn C. Henry, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1701-1747
Open Access | Times Cited: 7

Quantitative in Vivo Molecular MRI
Yingying Ning, Iris Y. Zhou, Peter Caravan
Advanced Materials (2024) Vol. 36, Iss. 44
Closed Access | Times Cited: 2

High-throughput screening in toxicity assessment
Kuldeep Rajpoot, Mamata Panchal, Bhakti Pawar, et al.
Elsevier eBooks (2024), pp. 407-449
Closed Access | Times Cited: 1

CMMS-GCL: cross-modality metabolic stability prediction with graph contrastive learning
Bing-Xue Du, Yahui Long, Xiaoli Li, et al.
Bioinformatics (2023) Vol. 39, Iss. 8
Open Access | Times Cited: 3

Anti-Inflammatory Effects of Auranamide and Patriscabratine—Mechanisms and In Silico Studies
Kit‐Kay Mak, Shiming Zhang, Jun Low, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4992-4992
Open Access | Times Cited: 3

High-Throughput Assay of Cytochrome P450-Dependent Drug Demethylation Reactions and Its Use to Re-Evaluate the Pathways of Ketamine Metabolism
Nadezhda Y. Davydova, David A. Hutner, Kari A. Gaither, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1055-1055
Open Access | Times Cited: 1

On drug discovery against infectious diseases and academic medicinal chemistry contributions
Yves L. Janin
Beilstein Journal of Organic Chemistry (2022) Vol. 18, pp. 1355-1378
Open Access | Times Cited: 1

Page 1

Scroll to top